An intent-to-treat analysis failed to reach significance for primary efficacy response versus placebo, but did attain significance for: (i) increased proportion of patients with a 50% reduction in swollen joint count (95% CI,1.52, 29.90) and swollen joint score (95% CI,0.91, 28.73), (ii) a reduced RF titer (95% CI, –303.7, –2.72), and (iii) improved blood hemoglobin.
← all excerpts
Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis.
1
—
—